The following list of peer-reviewed journal publications specifically use Kode™ Technology as the core technology in the publication.

These articles are viewable from - the academic resource for Kode Technology

Perry H, Bovin N & Henry S. A standardized kodecyte method to quantify ABO antibodies in undiluted plasma of patients before ABO incompatible kidney transplantation. Transfusion (2019);
DOI: 10.1111/trf.15247

Henry S & Bovin N. Kode technology – a universal cell surface glycan modification technology. J Royal Society of NZ (2018); 1 – 14
DOI: 10.1080/03036758.2018.1546195

Ryzhov I, Tuzikov A, Perry H, Korchagina E & Bovin N. Blood Group O - A Transformation by Chemical Ligation of Erythrocytes. ChemBioChem (2018); 20(2): 131 – 133
DOI: 10.1002/cbic.201800289

Ribeiro JP, Villringer S, Goyard D, Coche-Guerente L, Hoferlin M, Renaudet O, Römer W & Imberty A. Tailor-made Janus lectin with dual avidity assembles glycoconjugate multilayers and crosslinks protocells. Chemical Science (2018); 9: 7634-7641
DOI: 10.1039/c8sc02730g

Heider S, Reimhult E & Metzner C. Real-time analysis of protein and protein mixture interaction with lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes (2018); 1860(2): 319-328.
DOI: 10.1016/j.bbamem.2017.10.024

Henry S, Williams E, Barr K, Korchagina E, Tuzikov A, Ilyushina N & Bovin N. Rapid one-step biotinylation of biological or non-biological surfaces. Scientific Reports (2018), 8:2845
DOI: 10.1038/s41598-018-21186-3

Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Román-Sosa G, Dieterle ME, Kuehne AI, Muena NA, Wirchnianski AS, Nyakatura EK, Fels JM, Ng M, Mittler E, Pan J, Bharrhan S, Wec AZ, Lai JR, Sidhu SS, Tischler ND, Rey FA, Moffat J, Brummelkamp TR, Wang Z, Dye JM & Chandran K. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature (2018); 563(7732): 559-563.
DOI: 10.1038/s41586-018-0702-1

Ki KK, Faddy HM, Flower RL & Dean MM. Packed red blood cell transfusion modulates myeloid dendritic cell activation and inflammatory response in vitro. J Interferon & Cytokine Research (2018); 38: 111-121
DOI: 10.1089/jir.2017.0099

Naumenko V, Van S, Dastidar H, Kim D-S, Kim S-J, Zeng Z, Deniset J, Lau A, Zhang C, Macia N, Heyne B, Jenne CN & Mahoney DJ. Visualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital Microscopy. Molecular Therapy – Oncolytics (2018); 10: 14 – 27.
DOI: 10.1016/j.omto.2018.06.001

Villringer S, Madl J, Sych T, Manner C, Imberty A & Römer W. Lectin-mediated protocell crosslinking to mimic cell-cell junctions and adhesion. Scientific Reports (2018); 8(1): 1932
DOI: 10.1038/s41598-018-20230-6

Jesus C, Hesse C, Rocha C, Osório N, Valado A, Caseiro A, Gabriel A, Svensson L, Moslemi AR, Siba WA, Srour MA, Pereira C, Tomaz J, Teixeira P & Mendes F. Prevalence of antibodies to a new histo-blood system: the FORS system. Blood Transfusion (2018); 16(2): 178 – 183
DOI: 10.2450/2016.0120-16

Henry S, Perry H & Bovin N. Applications for kodecytes in immunohematology. ISBT Science Series (2017); 13(3): 229 – 237
DOI: 10.1111/voxs.12403

Lim YA & Kang SJ. Evaluation of kodecytes using function-spacer-lipid constructs as a survey material for external proficiency testing for ABO subgrouping. J Clin Lab Anal (2017); 31(6): e22116
DOI: 10.1002/jcla.22116

Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, Fels JM, He S, James RM, de La Vega MA, Zhu W, Bakken RR, Goodwin E, Turner HL, Jangra RK, Zeitlin L, Qiu X, Lai JR, Walker LM, Ward AB, Dye JM, Chandran K & Bornholdt ZA. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses. Cell (2017); 169(5): 878 – 890.e815
DOI: 10.1016/j.cell.2017.04.037.

Zhao X, Howell KA, He S, Brannan JM, Wec AZ, Davidson E, Turner HL, Chiang C-I, Lei L, Fels JM, Vu H, Shulenin S, Turonis AN, Kuehne AI, Liu G, Ta M, Wang Y, Sundling C, Xiao Y, Spence JS, Doranz BJ, Holtsberg FW, Ward AB, Chandran K, Dye JM, Qiu X, Li Y & Aman MJ. Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. Cell (2017); 169(5): 891 – 904.e815.
DOI: 10.1016/j.cell.2017.04.038.

Howell KA, Qiu X, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ, Shulenin S, Biggins JE, Douglas R, Enterlein SG, Turner HL, Pallesen J, Murin CD, He S, Kroeker A, Vu H, Herbert AS, Fusco ML, Nyakatura EK, Lai JR, Keck Z-Y, Foung SKH, Saphire EO, Zeitlin L, Ward AB, Chandran K, Doranz BJ, Kobinger GP, Dye JM & Aman MJ. Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Reports (2016); 15(7): 1514 – 1526
DOI: 10.1016/j.celrep.2016.04.026

Ki KK, Flower RL, Faddy HM & Dean MM. Incorporation of fluorescein conjugated function-spacer-lipid constructs into the red blood cell membrane facilitates detection of labeled cells for the duration of ex-vivo storage. J Immulogical Methods (2016); 429: 66-70.
DOI: 10.1016/j.jim.2016.01.003

Ryzhov IM, Korchagina EY, Tuzikov AB, Popova IS, Tyrtysh TV, Pazynina GV, Henry SM & Bovin NV. Function-Spacer-Lipid constructs of Lewis and chimeric Lewis/ABH glycans. Synthesis and use in serological studies. Carbohydrate Research (2016); 435: 83 96
DOI: 10.1016/j.carres.2016.09.016

Perry H, Bovin N & Henry S. Antibody complement-mediated hemolytic studies with kodecytes reveal human complement utilized in the classical pathway is more stable than generally accepted. Transfusion (2016); 56: 2495 – 2501
DOI: 10.1111/trf.13719

Williams E, Barr K, Korchagina E, Tuzikov A, Henry S & Bovin N. Ultra-fast glyco-coating of non-biological surfaces. Int. J. Mol. Sci. (2016); 17: 118
DOI: 10.3390/ijms17010118

Barr K, Kannan B, Korchagina E, Popova I, Ryzhov I, Henry S & Bovin N. Biofunctionalizing nanofibres with carbohydrate blood group antigens. Biopolymers (2016); 105: 787 – 794
DOI: 10.1002/bip.22907

Williams E, Korchagina E, Frame T, Ryzhov I, Bovin N & Henry S. Glycomapping the fine specificity of monoclonal and polyclonal Lewis antibodies with type-specific kodecytes and FSL constructs on paper. Transfusion (2016); 56: 325 – 333
DOI: 10.1111/trf.13384

Barr K, Korchagina E, Popova I, Bovin N & Henry S. Monoclonal anti-A activity against the FORS1 (Forssman) antigen. Transfusion (2015); 55: 129 – 136
DOI: 10.1111/trf.12773

Korchagina EY & Henry SM. Synthetic Glycolipid-like Constructs as Tools for Glycobiology Research, Diagnostics and as Potential Therapeutics. Biochemistry (Moscow) (2015); 80 (7): 857 – 871.
DOI: 10.1134/S0006297915070068

Kleinfelter LM, Jangra RK, Jae LT, Herbert AS, Mittler E, Stiles KM, Wirchnianski AS, Kielian M, Brummelkamp TR, Dye JM & Chandran K. Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. mBio (2015); 6(4): e00801-00815.
DOI: 10.1128/mBio.00801-15

Ng M, Ndungo E, Kaczmarek ME, Herbert AS, Binger T, Kuehne AI, Jangra RK, Hawkins JA, Gifford RJ, Biswas R, Demogines A, James RM, Yu M, Brummelkamp TR, Drosten C, Wang L-F, Kuhn JH, Müller MA, Dye JM, Sawyer SL & Chandran K. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. eLife (2015); 4: e11785
DOI: 10.7554/eLife.11785

Perry H & Henry S. Training students in serologic reaction grading increased perceptions of self-efficacy and ability to recognise serologic reactions but decreased grading accuracy. Transfusion (2015); 55(6): 1572 – 1579
DOI: 10.1111/trf.12985

Syed Azim SMS, Muhamad NA, Leong CF & Hussin NH. Comparison of Abtectcell III and Diamed red cell antibody screening kit for detection of clinically significant red cells alloantibody. Malaysian J Pathol (2015); 37(2): 109 – 114
Click here to read

Arnaud J, Tröndle K, Claudinon J, Audfray A, Varrot A, Römer W & Imberty A. Membrane Deformation by Neolectins with Engineered Glycolipid Binding Sites. Angew. Chem. Int. Ed. (2014); 53(35): 9267 – 9270
DOI: 10.1002/anie.201404568

Barr K, Korchagina E, Ryzhov I, Bovin N & Henry S. Mapping the fine specificity of ABO monoclonal reagents with A and B type-specific FSL constructs in kodecytes and inkjet printed on paper. Transfusion (2014); 54(10): 2477 – 2484
DOI: 10.1111/trf.12661

Ilyushina NA, Chernyy ES, Korchagina EY, Gambaryan AS, Henry SM & Bovin NV. Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids. Virologica Sinica (2014), 29(4): 199 – 210
DOI: 10.1007/s12250-014-3475-1

Ng, M., E. Ndungo, R. K. Jangra, Y. Cai, E. Postnikova, S. R. Radoshitzky, J. M. Dye, E. Ramírez de Arellano, A. Negredo, G. Palacios, J. H. Kuhn and K. Chandran. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann–Pick C1. Virology (2014); 468-470: 637 – 646.
DOI: 10.1016/j.virol.2014.08.019

Kurup, S. P. & Tarleton R. L. Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen. Nature Communications (2013); 4: 2616
DOI: 10.1038/ncomms3616

Tesfay MZ, Krik A, Hadac EM, Griesmann GE, Federspiel MJ, Barber GN, Henry SM, Peng K-W & Russell SJ. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. Journal of Virology (2013); 87(7): 3752 – 3759
DOI: 10.1128/JVI.02832-12

Georgakopoulos T, Komarraju S, Henry S & Bertolini J. An improved Fc function assay utilising CMV antigen coated red blood cells generated with synthetic Function-Spacer-Lipid constructs. Vox Sanguinis (2012); 102(1): 72 – 78
DOI: 10.1111/j.1423-0410.2011.01512.x

Henry S, Barr K & Oliver C. Modeling transfusion reactions with kodecytes and enabling ABO-incompatible transfusion with Function-Spacer-Lipid constructs. ISBT Science Series (2012); 7(1): 106 – 111
DOI: 10.1111/j.1751-2824.2012.01563.x

Hult AK, Frame T, Chesla S, Henry S & Olsson ML. Flow cytometry evaluation of red blood cells mimicking naturally-occurring ABO subgroups following modification with variable amounts of function-spacer-lipid A and B constructs. Transfusion (2012); 52(2): 247 – 251
DOI: 10.1111/j.1537-2995.2011.03268.x

Korchagina E, Tuzikov A, Formanovsky A, Popova I, Henry S & Bovin N. Toward creating cell membrane glycolandscapes with glycan lipid constructs. Carbohydrate Research (2012); 356: 238 – 246
DOI: 10.1038/s41598-018-21186-3

Lan C-C, Blake D, Henry S & Love DR. Fluorescent Function-Spacer-Lipid construct labelling allows for real-time in vivo imaging of cell migration and behaviour in zebrafish (Danio rerio). Journal of Fluorescence (2012); 22: 1055 – 1063
DOI: 10.1007/s10895-012-1043-3
Link to video examples

Mesman A. W., de Vries R. D., McQuaid S., Duprex W. P., de Swart R. L. & Geijtenbeek T. B. H. A Prominent Role for DC-SIGN+ Dendritic Cells in Initiation and Dissemination of Measles Virus Infection in Non-Human Primates. PLOS ONE (2012); 7(12): e49573.
DOI: 10.1371/journal.pone.0049573

Nadarajan VS, Laing AA, Saad SM & Usin M. Prevalence and specificity of red-blood-cell antibodies in a multiethnic South and East Asian patient population and influence of using novel MUT+Mur+ kodecytes on its detection. Vox Sanguinis (2011); 102: 65 – 71
DOI: 10.1111/j.1423-0410.2011.01507.x

Harrison AL, Henry S, Mahfoud R, Manis A, Albertini A, Gaudin Y, Lingwood CA & Branch DR. A novel VSV/HIV pseudotype approach for the study of HIV microbicides without requirement for level 3 biocontainment. Future Virology (2011); 6(10): 1241 – 1259
DOI: 10.2217/fvl.11.88

Blake DA, Bovin NV, Bess D, Henry SM. FSL Constructs: A Simple Method for Modifying Cell/Virion Surfaces with a Range of Biological Markers Without Affecting their Viability. J Visualized Experiments (2011) Aug 5; (54): e3289
DOI: 10.3791/3289 and example video

Henry SM, Komarraju S, Heathcote D & Rodinov I. Designing peptide-based FSL constructs to create Miltenberger kodecytes. ISBT Science Series (2011); 6: 306 – 312
DOI: 10.1111/j.1751-2824.2011.01505.x

Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S & Henry SM. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. J Virological Methods (2011); 176: 78 – 84
DOI: 10.1016/j.jviromet.2011.06.005

Oliver C, Blake D & Henry S. In vivo neutralization of anti-A and successful transfusion of A antigen incompatible red cells in an animal model. Transfusion (2011); 51: 2664 – 2675
DOI: 10.1111/j.1537-2995.2011.03184.x

Oliver C, Blake D & Henry S. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion (2011); 51: 1723 – 1730
DOI: 10.1111/j.1537-2995.2010.03034.x

Harrison, AL, Olsson ML, Brad Jones R, Ramkumar S, Sakac D, Binnington B, Henry S, Lingwood CA & Branch DR. A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconjugate (2010); 27: 515 – 524
DOI: 10.1007/s10719-010-9297-y

Heathcote D, Carroll T, Wang JJ, Flower R, Rodionov I, Tuzikov A, Bovin N & Henry S. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytes,. Transfusion (2010); 50: 635 – 641
DOI: 10.1111/j.1537-2995.2009.02480.x

Henry S. Modification of red blood cells for laboratory quality control use. Current Opinion in Hematology (2009); 16(6): 467 – 472
DOI: 10.1097/MOH.0b013e328331257e

Frame T, Carroll T, Korchagina E, Bovin N, & Henry S. Synthetic glycolipid modification of red blood cell membranes. Transfusion (2007); 47: 876 – 882
DOI: 10.1111/j.1537-2995.2007.01204.x